Medication Use Before and After Hip Fracture: A Population-Based Cohort and Case-Control Study

[1]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[2]  W. Yuan,et al.  Obesity and Risk of Hip Fracture in Adults: A Meta-Analysis of Prospective Cohort Studies , 2013, PloS one.

[3]  M. Crowell,et al.  Tricyclic antidepressant use and risk of fractures: A meta‐analysis of cohort and case‐control studies , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  W. Leslie,et al.  The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study , 2013, Osteoporosis International.

[5]  C. Cooper,et al.  Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women. , 2013, Bone.

[6]  C. Cooper,et al.  Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose , 2013, Osteoporosis International.

[7]  J. Reginster,et al.  Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants. , 2012, Bone.

[8]  C. Cooper,et al.  An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW) , 2012, Annals of the rheumatic diseases.

[9]  A. LaCroix,et al.  Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). , 2012, Bone.

[10]  H. Petri,et al.  Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States , 2012, Calcified Tissue International.

[11]  Sang Min Park,et al.  Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta‐analysis , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  L. Lix,et al.  A population-based analysis of the post-fracture care gap 1996–2008: the situation is not improving , 2012, Osteoporosis International.

[13]  P. Vestergaard,et al.  Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS) , 2012, Osteoporosis International.

[14]  C. Cooper,et al.  A systematic review of hip fracture incidence and probability of fracture worldwide , 2012, Osteoporosis International.

[15]  P. Piscitelli,et al.  [Incidence and socioeconomic burden of hip fractures in Italy]. , 2011, Reumatismo.

[16]  H. Mogun,et al.  Risk of fractures in older adults using antihypertensive medications , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  R. Eastell,et al.  Proton pump inhibitor use and the antifracture efficacy of alendronate. , 2011, Archives of internal medicine.

[18]  M. Berk,et al.  Paracetamol (acetaminophen) use, fracture and bone mineral density. , 2011, Bone.

[19]  C. Marcocci,et al.  [Guidelines for the diagnosis, prevention and treatment of osteoporosis]. , 2011, Reumatismo.

[20]  Isam Atroshi,et al.  Older Adults' Medication Use 6 Months Before and After Hip Fracture: A Population‐Based Cohort Study , 2011, Journal of the American Geriatrics Society.

[21]  Sang Min Park,et al.  Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies , 2011, The Annals of Family Medicine.

[22]  J. Cauley,et al.  Use of Antidepressant Medications and Risk of Fracture in Older Women , 2011, Calcified Tissue International.

[23]  Y. Loke,et al.  Meta-analysis: risk of fractures with acid-suppressing medication. , 2011, Bone.

[24]  J. Eisman,et al.  Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. , 2011, Bone.

[25]  T. Stürmer,et al.  Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis , 2011, Journal of the American Geriatrics Society.

[26]  A. Egberts,et al.  Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study , 2010, Osteoporosis International.

[27]  A. Distante,et al.  Hip fractures in Italy: 2000–2005 extension study , 2010, Osteoporosis International.

[28]  D. Riche,et al.  Bone Loss and Fracture Risk Associated with Thiazolidinedione Therapy , 2010, Pharmacotherapy.

[29]  J. Stevens,et al.  Declining hip fracture rates in the United States. , 2010, Age and Ageing.

[30]  C. Cooper,et al.  Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study , 2010, Osteoporosis International.

[31]  Ian D Cameron,et al.  Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: A prospective 5‐year study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Karim M Khan,et al.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons. , 2009, Archives of internal medicine.

[33]  A. LaCroix,et al.  Antiepileptic Drug Use, Falls, Fractures, and BMD in Postmenopausal Women: Findings From the Women's Health Initiative (WHI) , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  C. Cooper,et al.  Use of organic nitrates and the risk of hip fracture: a population-based case-control study. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  J. Reginster,et al.  Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study. , 2009, Bone.

[36]  T. Weiss,et al.  Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA) , 2009, Osteoporosis International.

[37]  C. Cooper,et al.  Use of anti-depressants and the risk of fracture of the hip or femur , 2009, Osteoporosis International.

[38]  C. Cooper,et al.  Use of anti-depressants and the risk of fracture of the hip or femur , 2009, Osteoporosis International.

[39]  P. Eiken,et al.  Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence , 2009, Osteoporosis International.

[40]  A. LaCroix,et al.  Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative. , 2009, Archives of internal medicine.

[41]  C. Cooper,et al.  Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study , 2009, Osteoporosis International.

[42]  P. Vestergaard,et al.  Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. , 2007, Chest.

[43]  J. Eisman,et al.  Risk of subsequent fracture after low-trauma fracture in men and women. , 2007, JAMA.

[44]  A. Distante,et al.  Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey , 2007, Osteoporosis International.

[45]  S. Silverman,et al.  Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study , 2006, Osteoporosis International.

[46]  W. Willett,et al.  Prospective Study of Diabetes and Risk of Hip Fracture , 2006, Diabetes Care.

[47]  H. Kroger,et al.  Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.

[48]  Niklas Zethraeus,et al.  Assessment of fracture risk , 2005, Osteoporosis International.

[49]  J. Cauley,et al.  Hip fracture in women without osteoporosis. , 2005, The Journal of clinical endocrinology and metabolism.

[50]  Maryann M Fulton,et al.  Polypharmacy in the elderly: A literature review , 2005, Journal of the American Academy of Nurse Practitioners.

[51]  R Nuti,et al.  Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. , 2005, Bone.

[52]  D. Lawlor,et al.  Association between falls in elderly women and chronic diseases and drug use: cross sectional study , 2003, BMJ : British Medical Journal.

[53]  J. Evans.  Drugs and falls in later life , 2003, The Lancet.

[54]  C. Maxwell,et al.  Medication use and risk of falls , 2002, Pharmacoepidemiology and drug safety.

[55]  T. S. Wei,et al.  Fall Characterictics, Functional Mobility and Bone Mineral Density as Risk Factors of Hip Fracture in the Community-Dwelling Ambulatory Elderly , 2001, Osteoporosis International.

[56]  F. Luyten,et al.  Bone densitometry is not a good predictor of hip fracture. , 2001, BMJ.

[57]  Jacques LeLorier,et al.  Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses , 1999, PharmacoEconomics.

[58]  M. Tinetti,et al.  Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: II. Cardiac and Analgesic Drugs , 1999, Journal of the American Geriatrics Society.

[59]  M. Tinetti,et al.  Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs , 1999, Journal of the American Geriatrics Society.

[60]  R. Norton,et al.  Circumstances of Falls Resulting in Hip Fractures Among Older People , 1997, Journal of the American Geriatrics Society.

[61]  B. Motheral,et al.  The use of claims databases for outcomes research: rationale, challenges, and strategies. , 1997, Clinical therapeutics.

[62]  R. Klineberg,et al.  Psychotropics, thiazide diuretics and hip fractures in the elderly , 1993, The Medical journal of Australia.

[63]  J. Kanis,et al.  Assessing the Impact of Osteoporosis on the Burden of Hip Fractures , 2012, Calcified Tissue International.

[64]  M. Crowell,et al.  Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies , 2011, Osteoporosis International.

[65]  C. Trevisan,et al.  il costo delle fratture da osteoporosi in italia. Risultati dello studio BloCK ( Bone Loss and Osteoporosis: Cost-of-illness Knowledge) , 2011 .

[66]  M. Roizen.  Chronic Musculoskeletal Pain and the Occurrence of Falls in an Older Population , 2010 .

[67]  A. Darowski,et al.  Antidepressants and Falls in the Elderly , 2009, Drugs & aging.

[68]  G. Dinant,et al.  Risk of new clinical fractures within 2 years following a fracture , 2005, Osteoporosis International.

[69]  R. Cumming,et al.  Benzodiazepines and Risk of Hip Fractures in Older People , 2003, CNS drugs.